All posts by : Felistas

Peter H. Gilligan, Ph.D., D(ABMM) emeritus and F(AAM) was a medical microbiologist at UNC Health for 35 years. Here, he reflects on the value of vaccines observed throughout his lifetime.

Monash University scientists have developed a new (preclinical) method to distinguish between chronic pain subtypes, such as fibromyalgia and peripheral neuropathy.

Ozempic and similar semaglutide-based medications have been hailed as miracle drugs. Known as GLP-1 (glucagon-like peptide-1) agonists, this class of medications mimics a natural hormone the small intestine releases after you eat. They slow the movement of food through the gut and boost insulin production, increasing the feeling of fullness and suppressing appetite.

Short activity breaks throughout the day together with high-intensity interval training (HIIT) every other day can counteract negative changes in heart health associated with a sedentary lifestyle. The study is published in the Journal of Applied Physiology and has been chosen as an APSselect article for April.

University of Montreal-led research has found that children who sustain concussion may need three months or longer to be considered optimally recovered across physical, cognitive, socioemotional, and resilience domains.

Collaborative, community-driven initiatives can help mitigate the impact of opioid misuse and overdose deaths, according to a research team that includes Brandy Henry, assistant professor of rehabilitation and human services in the Penn State College of Education.

Meeting the unmet need for a vaccine is the top priority for researchers studying Lyme disease, which infects about 476,000 people in the U.S. each year and can come with severe complications such as ongoing fatigue and joint issues. Vaccine developers have come close to success, but no human vaccine has yet been commercially viable.

As artificial intelligence (AI) rapidly integrates into health care, a study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may recommend different treatments for the same medical condition based solely on a patient’s socioeconomic and demographic background.

Even in the case of uncomplicated infections, the body prepares itself early on for the possibility of a more severe course. A research team from the Technical University of Munich (TUM) and Helmholtz Munich has now uncovered this mechanism. The scientists showed that, right at the onset of mild illness, the body also produces special T cells previously known only from chronic, severe infections and tumors.

Howard Hughes Medical Institute-led research has produced a complete connectome of the Drosophila visual system, enabling systematic investigations into how visual information is processed and relayed to the central brain.